| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 19 | 2023 | 1008 | 1.700 |
Why?
|
| Pregnancy | 64 | 2023 | 7600 | 1.230 |
Why?
|
| Pregnancy Complications, Infectious | 8 | 2017 | 492 | 0.970 |
Why?
|
| Pregnancy Outcome | 12 | 2018 | 637 | 0.870 |
Why?
|
| Amniocentesis | 4 | 2014 | 77 | 0.770 |
Why?
|
| Pregnancy Complications | 10 | 2016 | 553 | 0.760 |
Why?
|
| Fetal Diseases | 5 | 2015 | 462 | 0.570 |
Why?
|
| Prenatal Diagnosis | 3 | 2017 | 633 | 0.500 |
Why?
|
| Body Mass Index | 2 | 2015 | 1722 | 0.480 |
Why?
|
| Pertussis Vaccine | 1 | 2015 | 25 | 0.470 |
Why?
|
| Pregnancy Complications, Cardiovascular | 4 | 2007 | 105 | 0.460 |
Why?
|
| Organ Transplantation | 2 | 2008 | 183 | 0.430 |
Why?
|
| Female | 69 | 2023 | 72054 | 0.400 |
Why?
|
| Pregnancy Trimester, Second | 9 | 2023 | 170 | 0.400 |
Why?
|
| Antibodies, Bacterial | 1 | 2015 | 407 | 0.400 |
Why?
|
| Prenatal Care | 4 | 2019 | 360 | 0.390 |
Why?
|
| Birth Weight | 4 | 2020 | 356 | 0.390 |
Why?
|
| Povidone-Iodine | 1 | 2012 | 10 | 0.380 |
Why?
|
| Chlorhexidine | 1 | 2012 | 49 | 0.370 |
Why?
|
| Vena Cava, Inferior | 2 | 2007 | 103 | 0.370 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2012 | 71 | 0.360 |
Why?
|
| Electronic Nicotine Delivery Systems | 3 | 2017 | 58 | 0.350 |
Why?
|
| Adult | 40 | 2021 | 31962 | 0.340 |
Why?
|
| Nicotine | 3 | 2017 | 147 | 0.340 |
Why?
|
| alpha-Fetoproteins | 2 | 2015 | 134 | 0.330 |
Why?
|
| Vaccination | 1 | 2015 | 1019 | 0.320 |
Why?
|
| Delivery, Obstetric | 2 | 2019 | 260 | 0.310 |
Why?
|
| Streptococcus agalactiae | 1 | 2009 | 103 | 0.300 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2009 | 129 | 0.290 |
Why?
|
| Humans | 73 | 2023 | 134225 | 0.290 |
Why?
|
| Glucocorticoids | 2 | 2001 | 401 | 0.290 |
Why?
|
| Congenital Abnormalities | 2 | 2009 | 301 | 0.290 |
Why?
|
| Trichomonas Vaginitis | 1 | 2008 | 14 | 0.290 |
Why?
|
| Genetic Testing | 2 | 2018 | 1105 | 0.290 |
Why?
|
| Pre-Eclampsia | 5 | 2017 | 230 | 0.280 |
Why?
|
| Anxiety | 3 | 2009 | 1004 | 0.280 |
Why?
|
| Varicose Veins | 1 | 2007 | 31 | 0.270 |
Why?
|
| Streptococcal Infections | 1 | 2009 | 248 | 0.270 |
Why?
|
| Pelvis | 1 | 2007 | 74 | 0.270 |
Why?
|
| Glaucoma | 3 | 1996 | 89 | 0.260 |
Why?
|
| Gestational Age | 10 | 2021 | 1230 | 0.250 |
Why?
|
| Obstetric Labor Complications | 2 | 2005 | 99 | 0.250 |
Why?
|
| Pregnancy Trimester, First | 4 | 2018 | 123 | 0.250 |
Why?
|
| Infant, Newborn | 17 | 2021 | 8640 | 0.240 |
Why?
|
| Parvovirus B19, Human | 1 | 2005 | 31 | 0.240 |
Why?
|
| Parvoviridae Infections | 1 | 2005 | 37 | 0.240 |
Why?
|
| Hydrocephalus | 1 | 2008 | 276 | 0.240 |
Why?
|
| Chromosome Disorders | 2 | 2018 | 316 | 0.240 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2005 | 25 | 0.230 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2003 | 98 | 0.230 |
Why?
|
| Genetic Counseling | 3 | 2014 | 246 | 0.230 |
Why?
|
| Fetal Organ Maturity | 2 | 2001 | 14 | 0.230 |
Why?
|
| Hydatidiform Mole | 1 | 2005 | 20 | 0.230 |
Why?
|
| Umbilical Cord | 1 | 2005 | 59 | 0.220 |
Why?
|
| Betamethasone | 2 | 2001 | 14 | 0.220 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2005 | 66 | 0.220 |
Why?
|
| Obstetric Labor, Premature | 3 | 2001 | 85 | 0.220 |
Why?
|
| Fetal Growth Retardation | 3 | 2020 | 257 | 0.220 |
Why?
|
| Humerus | 1 | 2004 | 16 | 0.220 |
Why?
|
| Vaginosis, Bacterial | 2 | 2000 | 19 | 0.210 |
Why?
|
| Neck | 1 | 2005 | 143 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2005 | 112 | 0.210 |
Why?
|
| Psychological Tests | 1 | 2023 | 94 | 0.210 |
Why?
|
| Maternal Exposure | 2 | 2015 | 156 | 0.210 |
Why?
|
| Pain | 2 | 2004 | 476 | 0.210 |
Why?
|
| Perception | 3 | 2017 | 237 | 0.200 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2020 | 60 | 0.200 |
Why?
|
| Kidney Transplantation | 1 | 2008 | 575 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 2 | 2012 | 2592 | 0.200 |
Why?
|
| Smoking | 3 | 2017 | 1136 | 0.200 |
Why?
|
| Placenta Previa | 1 | 2023 | 67 | 0.190 |
Why?
|
| Ultrasonography, Doppler | 3 | 2019 | 198 | 0.190 |
Why?
|
| Reproductive Health | 1 | 2022 | 49 | 0.190 |
Why?
|
| Burnout, Professional | 1 | 2023 | 130 | 0.180 |
Why?
|
| Cocaine | 1 | 2003 | 208 | 0.180 |
Why?
|
| Liver Transplantation | 2 | 2008 | 1122 | 0.180 |
Why?
|
| Fetal Weight | 2 | 2020 | 72 | 0.180 |
Why?
|
| Placenta | 3 | 2023 | 550 | 0.180 |
Why?
|
| Obstetrics | 4 | 2021 | 240 | 0.180 |
Why?
|
| Cocaine-Related Disorders | 1 | 2003 | 204 | 0.170 |
Why?
|
| Down Syndrome | 1 | 2004 | 232 | 0.170 |
Why?
|
| Counseling | 1 | 2022 | 241 | 0.170 |
Why?
|
| Cohort Studies | 7 | 2021 | 5225 | 0.170 |
Why?
|
| Self Report | 1 | 2023 | 553 | 0.170 |
Why?
|
| Lymphangioma | 1 | 2000 | 25 | 0.170 |
Why?
|
| Glucose Intolerance | 1 | 2001 | 85 | 0.170 |
Why?
|
| Diseases in Twins | 1 | 2000 | 99 | 0.160 |
Why?
|
| Twins, Monozygotic | 1 | 2000 | 129 | 0.160 |
Why?
|
| Laser Therapy | 3 | 1996 | 229 | 0.160 |
Why?
|
| Sclerostomy | 2 | 1996 | 3 | 0.160 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 1999 | 23 | 0.150 |
Why?
|
| Microvessels | 1 | 2019 | 63 | 0.150 |
Why?
|
| Tachycardia | 1 | 2018 | 70 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2019 | 61 | 0.150 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2000 | 344 | 0.140 |
Why?
|
| Placenta Accreta | 1 | 2021 | 169 | 0.140 |
Why?
|
| Motor Activity | 1 | 2021 | 531 | 0.140 |
Why?
|
| Diabetes, Gestational | 2 | 2015 | 115 | 0.140 |
Why?
|
| Citrobacter | 1 | 1997 | 21 | 0.140 |
Why?
|
| Physicians, Family | 1 | 2017 | 38 | 0.140 |
Why?
|
| Neural Tube Defects | 1 | 2021 | 359 | 0.140 |
Why?
|
| Triplets | 1 | 1997 | 12 | 0.140 |
Why?
|
| Enterobacteriaceae Infections | 1 | 1997 | 59 | 0.130 |
Why?
|
| Twins | 1 | 1997 | 74 | 0.130 |
Why?
|
| Surgical Flaps | 2 | 1996 | 197 | 0.130 |
Why?
|
| Cannabis | 1 | 2017 | 52 | 0.130 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2016 | 18 | 0.130 |
Why?
|
| Hyperemesis Gravidarum | 1 | 1996 | 5 | 0.130 |
Why?
|
| Physicians | 1 | 2023 | 641 | 0.130 |
Why?
|
| Ciliary Body | 1 | 1996 | 28 | 0.130 |
Why?
|
| Hyperthyroidism | 1 | 1996 | 26 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 155 | 0.130 |
Why?
|
| Birth Rate | 1 | 2016 | 17 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 59 | 0.130 |
Why?
|
| Blood Glucose | 1 | 2001 | 1196 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 67 | 0.120 |
Why?
|
| Patient Selection | 2 | 2016 | 734 | 0.120 |
Why?
|
| Marijuana Smoking | 1 | 2016 | 33 | 0.120 |
Why?
|
| Infant, Premature | 1 | 2001 | 857 | 0.120 |
Why?
|
| Pregnancy Trimester, Third | 3 | 2020 | 124 | 0.120 |
Why?
|
| Genes, Homeobox | 1 | 1995 | 72 | 0.120 |
Why?
|
| Fast Foods | 1 | 2015 | 35 | 0.120 |
Why?
|
| Aspirin | 1 | 2017 | 231 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1997 | 226 | 0.120 |
Why?
|
| Retrospective Studies | 11 | 2023 | 17591 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1997 | 255 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 1995 | 17 | 0.120 |
Why?
|
| Commerce | 1 | 2015 | 57 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 317 | 0.110 |
Why?
|
| Hand Deformities, Congenital | 1 | 1995 | 95 | 0.110 |
Why?
|
| Food Supply | 1 | 2015 | 101 | 0.110 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2015 | 128 | 0.110 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 175 | 0.110 |
Why?
|
| Cesarean Section | 3 | 2021 | 402 | 0.110 |
Why?
|
| Pregnancy, High-Risk | 2 | 2008 | 43 | 0.110 |
Why?
|
| Time Factors | 4 | 2009 | 6595 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2000 | 703 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 1997 | 411 | 0.110 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 85 | 0.100 |
Why?
|
| Referral and Consultation | 4 | 2008 | 574 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2023 | 1255 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 657 | 0.100 |
Why?
|
| Lung | 1 | 2000 | 1578 | 0.100 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 5466 | 0.100 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 680 | 0.100 |
Why?
|
| Maternal Age | 4 | 2017 | 141 | 0.090 |
Why?
|
| Apgar Score | 2 | 2018 | 49 | 0.090 |
Why?
|
| Chromatin | 1 | 2015 | 617 | 0.090 |
Why?
|
| Fetus | 1 | 2015 | 601 | 0.090 |
Why?
|
| Spinal Dysraphism | 1 | 2015 | 274 | 0.090 |
Why?
|
| Decision Making | 4 | 2014 | 701 | 0.090 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1161 | 0.090 |
Why?
|
| Risk Assessment | 4 | 2015 | 3754 | 0.090 |
Why?
|
| Costs and Cost Analysis | 2 | 2009 | 166 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1051 | 0.080 |
Why?
|
| Circumcision, Male | 2 | 2002 | 25 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2008 | 3869 | 0.080 |
Why?
|
| Glucose Tolerance Test | 2 | 2001 | 227 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1762 | 0.080 |
Why?
|
| Texas | 5 | 2019 | 3719 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3678 | 0.080 |
Why?
|
| Pilot Projects | 3 | 2009 | 1493 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 334 | 0.080 |
Why?
|
| Skin | 1 | 2012 | 545 | 0.080 |
Why?
|
| Transplantation Immunology | 1 | 2008 | 46 | 0.070 |
Why?
|
| Pancreas Transplantation | 1 | 2008 | 31 | 0.070 |
Why?
|
| Calcineurin Inhibitors | 1 | 2008 | 29 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2000 | 1885 | 0.070 |
Why?
|
| Cerebral Ventricles | 1 | 2008 | 84 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 606 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 738 | 0.070 |
Why?
|
| Antiprotozoal Agents | 1 | 2008 | 42 | 0.070 |
Why?
|
| United States | 6 | 2021 | 11798 | 0.070 |
Why?
|
| Postoperative Period | 1 | 2008 | 339 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1044 | 0.070 |
Why?
|
| Metronidazole | 1 | 2008 | 157 | 0.070 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2007 | 71 | 0.070 |
Why?
|
| Intraocular Pressure | 3 | 1996 | 136 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2023 | 4008 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2009 | 319 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2000 | 1982 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2007 | 168 | 0.060 |
Why?
|
| Transcription Factors | 1 | 1995 | 2735 | 0.060 |
Why?
|
| Obesity, Morbid | 1 | 2008 | 214 | 0.060 |
Why?
|
| Cerebral Veins | 1 | 2005 | 18 | 0.060 |
Why?
|
| Overweight | 1 | 2008 | 387 | 0.060 |
Why?
|
| Alkalosis | 1 | 2004 | 24 | 0.060 |
Why?
|
| Risk Factors | 4 | 2018 | 11196 | 0.060 |
Why?
|
| Hypercalcemia | 1 | 2004 | 42 | 0.060 |
Why?
|
| Tomography, Spiral Computed | 1 | 2004 | 16 | 0.060 |
Why?
|
| Dysmenorrhea | 1 | 2004 | 15 | 0.060 |
Why?
|
| Lung Transplantation | 1 | 2008 | 337 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 604 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 176 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2008 | 577 | 0.050 |
Why?
|
| DNA, Viral | 1 | 2005 | 500 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2021 | 13105 | 0.050 |
Why?
|
| Aortic Coarctation | 1 | 2005 | 108 | 0.050 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2001 | 62 | 0.050 |
Why?
|
| Bacteriological Techniques | 2 | 2000 | 90 | 0.050 |
Why?
|
| Male | 10 | 2021 | 66215 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2005 | 1003 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 1222 | 0.050 |
Why?
|
| Recurrence | 2 | 2017 | 1470 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2004 | 369 | 0.050 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 87 | 0.050 |
Why?
|
| Biomarkers | 2 | 2009 | 3434 | 0.050 |
Why?
|
| Pamphlets | 1 | 2002 | 24 | 0.050 |
Why?
|
| Third-Party Consent | 1 | 2002 | 28 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2002 | 85 | 0.050 |
Why?
|
| Limb Deformities, Congenital | 1 | 2003 | 112 | 0.050 |
Why?
|
| Pulmonary Embolism | 1 | 2004 | 190 | 0.050 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2171 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 723 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1344 | 0.050 |
Why?
|
| Body Height | 1 | 2003 | 230 | 0.050 |
Why?
|
| Heart Transplantation | 1 | 2008 | 889 | 0.050 |
Why?
|
| Education | 1 | 2002 | 111 | 0.050 |
Why?
|
| Syndrome | 4 | 2007 | 1176 | 0.040 |
Why?
|
| Edema | 1 | 2002 | 148 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 906 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2003 | 224 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2003 | 635 | 0.040 |
Why?
|
| Blood Chemical Analysis | 2 | 2015 | 88 | 0.040 |
Why?
|
| Medicaid | 2 | 2017 | 254 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2001 | 198 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2000 | 139 | 0.040 |
Why?
|
| Hysterotomy | 1 | 2021 | 127 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2001 | 335 | 0.040 |
Why?
|
| Extraembryonic Membranes | 1 | 2000 | 14 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2000 | 187 | 0.040 |
Why?
|
| Chromosome Aberrations | 2 | 2016 | 628 | 0.040 |
Why?
|
| Genetic Heterogeneity | 2 | 2003 | 143 | 0.040 |
Why?
|
| Gram-Positive Bacteria | 1 | 2000 | 49 | 0.040 |
Why?
|
| Labor, Induced | 1 | 2000 | 34 | 0.040 |
Why?
|
| Gram-Negative Bacteria | 1 | 2000 | 74 | 0.040 |
Why?
|
| Cicatrix | 1 | 2021 | 128 | 0.040 |
Why?
|
| Dietary Carbohydrates | 1 | 2000 | 117 | 0.040 |
Why?
|
| Gynecology | 1 | 2021 | 129 | 0.040 |
Why?
|
| Logistic Models | 1 | 2004 | 1909 | 0.040 |
Why?
|
| Pedigree | 3 | 2003 | 1732 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 20 | 0.040 |
Why?
|
| South America | 1 | 2019 | 42 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 753 | 0.040 |
Why?
|
| Women's Health Services | 1 | 2019 | 14 | 0.040 |
Why?
|
| Echocardiography | 1 | 2005 | 1132 | 0.040 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 1998 | 10 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2005 | 1205 | 0.040 |
Why?
|
| Consensus | 1 | 2022 | 728 | 0.040 |
Why?
|
| Vagina | 1 | 2000 | 205 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2003 | 838 | 0.040 |
Why?
|
| Breast Diseases | 1 | 1998 | 38 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 190 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 768 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 61 | 0.040 |
Why?
|
| Lidocaine | 1 | 1998 | 48 | 0.040 |
Why?
|
| Europe | 1 | 1999 | 382 | 0.040 |
Why?
|
| Infant Mortality | 1 | 1999 | 180 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2003 | 948 | 0.040 |
Why?
|
| Animals | 4 | 2015 | 36526 | 0.040 |
Why?
|
| Conjunctiva | 2 | 1996 | 194 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 1998 | 90 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2018 | 136 | 0.030 |
Why?
|
| Nerve Block | 1 | 1998 | 67 | 0.030 |
Why?
|
| Lactation | 1 | 1998 | 200 | 0.030 |
Why?
|
| Tobacco Products | 1 | 2017 | 72 | 0.030 |
Why?
|
| Diathermy | 1 | 1996 | 4 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1512 | 0.030 |
Why?
|
| Parity | 1 | 1997 | 89 | 0.030 |
Why?
|
| Trabecular Meshwork | 1 | 1996 | 11 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1997 | 136 | 0.030 |
Why?
|
| Brain | 2 | 2001 | 3226 | 0.030 |
Why?
|
| Aqueous Humor | 1 | 1996 | 28 | 0.030 |
Why?
|
| Fetoscopy | 1 | 2021 | 449 | 0.030 |
Why?
|
| Receptors, Thyrotropin | 1 | 1996 | 12 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2004 | 704 | 0.030 |
Why?
|
| Patient Transfer | 1 | 1998 | 110 | 0.030 |
Why?
|
| Ultrasonic Therapy | 1 | 1996 | 29 | 0.030 |
Why?
|
| Gravidity | 1 | 2016 | 12 | 0.030 |
Why?
|
| Glaucoma, Neovascular | 1 | 1996 | 2 | 0.030 |
Why?
|
| Population | 1 | 2016 | 24 | 0.030 |
Why?
|
| Uterus | 1 | 2021 | 587 | 0.030 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1996 | 13 | 0.030 |
Why?
|
| Cryosurgery | 1 | 1996 | 49 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2021 | 780 | 0.030 |
Why?
|
| Glaucoma, Open-Angle | 1 | 1996 | 36 | 0.030 |
Why?
|
| Chorionic Gonadotropin | 1 | 1996 | 82 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 1997 | 239 | 0.030 |
Why?
|
| MSX1 Transcription Factor | 1 | 1995 | 15 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 1193 | 0.030 |
Why?
|
| Muscular Dystrophies | 1 | 1996 | 54 | 0.030 |
Why?
|
| Consanguinity | 1 | 1996 | 120 | 0.030 |
Why?
|
| Lod Score | 1 | 1995 | 128 | 0.030 |
Why?
|
| Environment Design | 1 | 2015 | 17 | 0.030 |
Why?
|
| Geographic Mapping | 1 | 2015 | 15 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 90 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2015 | 41 | 0.030 |
Why?
|
| Gallbladder Diseases | 1 | 1995 | 26 | 0.030 |
Why?
|
| Growth Substances | 1 | 1995 | 114 | 0.030 |
Why?
|
| Laser Coagulation | 1 | 1996 | 129 | 0.030 |
Why?
|
| Rupture | 1 | 1995 | 34 | 0.030 |
Why?
|
| Hypotension | 1 | 1997 | 190 | 0.030 |
Why?
|
| Extremities | 1 | 1995 | 87 | 0.030 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2016 | 77 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 232 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 196 | 0.030 |
Why?
|
| Focus Groups | 1 | 2015 | 213 | 0.030 |
Why?
|
| Ovary | 1 | 1997 | 390 | 0.030 |
Why?
|
| Morphogenesis | 1 | 1995 | 215 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 1995 | 134 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2319 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 400 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2000 | 983 | 0.030 |
Why?
|
| Microcephaly | 1 | 2017 | 354 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 183 | 0.030 |
Why?
|
| RNA Splicing | 1 | 2015 | 254 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 485 | 0.030 |
Why?
|
| Mutation | 1 | 2007 | 6350 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 237 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 293 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2016 | 1338 | 0.020 |
Why?
|
| Middle Aged | 4 | 2017 | 29430 | 0.020 |
Why?
|
| Thrombosis | 1 | 1997 | 547 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 1995 | 589 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 833 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1308 | 0.020 |
Why?
|
| Premature Birth | 1 | 2016 | 419 | 0.020 |
Why?
|
| Mass Screening | 1 | 2017 | 845 | 0.020 |
Why?
|
| Young Adult | 2 | 2015 | 9963 | 0.020 |
Why?
|
| Base Sequence | 1 | 1995 | 3181 | 0.020 |
Why?
|
| Prevalence | 1 | 2017 | 2685 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3978 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3056 | 0.020 |
Why?
|
| Adolescent | 5 | 2015 | 20647 | 0.020 |
Why?
|
| Incidence | 1 | 1997 | 3424 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 3759 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 3876 | 0.020 |
Why?
|
| Asthma | 1 | 2016 | 812 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 1409 | 0.020 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2007 | 20 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 1996 | 7244 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1995 | 2178 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2008 | 145 | 0.020 |
Why?
|
| Insurance Coverage | 1 | 2008 | 125 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 1419 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 13263 | 0.020 |
Why?
|
| Trachea | 1 | 2007 | 212 | 0.020 |
Why?
|
| Brachiocephalic Trunk | 1 | 2005 | 40 | 0.010 |
Why?
|
| Diphosphonates | 1 | 2004 | 43 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 2004 | 149 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2003 | 18 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 479 | 0.010 |
Why?
|
| Rare Diseases | 1 | 2004 | 209 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2003 | 124 | 0.010 |
Why?
|
| Culture | 1 | 2002 | 73 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 2004 | 563 | 0.010 |
Why?
|
| Attitude | 1 | 2002 | 122 | 0.010 |
Why?
|
| Hedgehog Proteins | 1 | 2003 | 268 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2004 | 1312 | 0.010 |
Why?
|
| Educational Status | 1 | 2002 | 298 | 0.010 |
Why?
|
| Aged | 2 | 1996 | 21822 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2000 | 147 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2000 | 78 | 0.010 |
Why?
|
| Postnatal Care | 1 | 2000 | 52 | 0.010 |
Why?
|
| Crying | 1 | 1998 | 12 | 0.010 |
Why?
|
| Penis | 1 | 1998 | 104 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2000 | 6617 | 0.010 |
Why?
|
| Dandy-Walker Syndrome | 1 | 1996 | 11 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1995 | 50 | 0.010 |
Why?
|
| Electromyography | 1 | 1996 | 141 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1996 | 204 | 0.010 |
Why?
|
| Puerperal Disorders | 1 | 1995 | 47 | 0.010 |
Why?
|
| Prothrombin Time | 1 | 1995 | 38 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1995 | 62 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1995 | 50 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1996 | 482 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1995 | 163 | 0.010 |
Why?
|
| Haplotypes | 1 | 1996 | 559 | 0.010 |
Why?
|
| Ophthalmic Solutions | 1 | 1994 | 90 | 0.010 |
Why?
|
| Registries | 1 | 2000 | 1588 | 0.010 |
Why?
|
| Alleles | 1 | 1996 | 1724 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 1043 | 0.000 |
Why?
|
| Cornea | 1 | 1994 | 598 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 2204 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1994 | 3172 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1996 | 14897 | 0.000 |
Why?
|
| Child | 1 | 1996 | 25917 | 0.000 |
Why?
|